Results 181 to 190 of about 6,976 (207)

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis

Annals of Medicine, 2022
Mingwei W, Feng Zhanhui, Jiake Tang
exaly  

Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

International Journal of Antimicrobial Agents, 2023
Fangyuan Tian
exaly  

LC and LC-HRMS studies on stability behavior of molnupiravir an anti-COVID 19 drug

Journal of Liquid Chromatography and Related Technologies, 2021
Ravi P Shāh, Nitish Sharma, Sonali Jain
exaly  

Molnupiravir for Covid-19 in Nonhospitalized Patients

New England Journal of Medicine, 2022
Kristian, Thorlund, Kyle, Sheldrick, Edward, Mills   +2 more
openaire   +5 more sources

Molnupiravir: A new candidate for COVID-19 treatment

Pharmacology Research and Perspectives, 2022
Fariba Pourkarim, Haleh Rezaee, Samira Pourtaghi-Anvarian   +2 more
exaly  

Transfer and biotransformation of the COVID-19 prodrug molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-placenta barrier

EBioMedicine, 2023
Jeffrey W Dalley, Tung-Hu Tsai, Wen-Ya Peng   +2 more
exaly  

PROCESS FOR THE PREPARATION OF MOLNUPIRAVIR

2022
DIVI MURALI KRISHNA PRASAD, RAO MYSORE ASWATHANARAYANA   +1 more
openaire   +3 more sources

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

International Journal of Antimicrobial Agents, 2023
Iker Falces-Romero, Francesco Marchesi, Oliver A. Cornely   +2 more
exaly  

Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data

Journal of Clinical Medicine, 2023
Domenico Motola, Nicola Montanaro, Greta Santi Laurini   +2 more
exaly  

Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review

Irish Journal of Medical Science, 2022
Gerard Marshall Raj, Madhavi Eerike, Rekha Priyadarshini   +2 more
exaly